Good Growth Capital, a majority women- and minority-managed fund, has announced the completion of the oversubscribed third fund, Good Growth Capital General Fund II, with more than $100m that will be deployed in Seed through Series B investments.

General Fund II, similar to prior Good Growth Capital investment vehicles, will be dedicated to investing in data science, biomed tech, green tech, and other hard science industries. Good Growth Capital is the most active venture capital firm in the state of South Carolina; the firm also has a Boston office, and its network of experienced venture partners and advisors operate in multiple US cities to assist with deal flow and due diligence.

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter

“Now having over $100 million to deploy allows us to put more money to work in businesses that will make a positive impact on the world,” said Good Growth Capital Managing Partner and Founder Amy Salzhauer. “We could not be more excited about the future of Good Growth and our current and future portfolio companies.”

Good Growth Capital closed its first General Fund in 2017, which is fully invested and today has returned over 35% of capital invested and is projected to earn top-decile returns over the life of the fund. In 2020, Good Growth Capital also closed its second fund, Infinite Corridor Fund I, which today is fully allocated and focused on pre-seed round deals and development capital.

Managing Partners Carolyne LaSala; David Mendez; and John Osborne will round out the leadership team for this fund. Together, Good Growth Capital’s five managing partners have collectively launched 18 business generating billions in return for relevant stakeholders. Their Venture Partners and Advisors have started another 30+ companies.

Source: Business Wire

Can’t stop reading? Read more